These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37186566)

  • 21. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.
    Ten Cate H; Guzik TJ; Eikelboom J; Spronk HMH
    Cardiovasc Res; 2021 Jul; 117(9):2030-2044. PubMed ID: 32931586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-platelet therapy in patients with acute coronary syndromes].
    Kopaleishvili LA; Dzhashi IM
    Georgian Med News; 2014 Nov; (236):105-10. PubMed ID: 25541837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Kiouptsi K; Jäckel S; Pontarollo G; Grill A; Kuijpers MJE; Wilms E; Weber C; Sommer F; Nagy M; Neideck C; Jansen Y; Ascher S; Formes H; Karwot C; Bayer F; Kollar B; Subramaniam S; Molitor M; Wenzel P; Rosenstiel P; Todorov H; Gerber S; Walter U; Jurk K; Heemskerk JWM; van der Vorst EPC; Döring Y; Reinhardt C
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Tissue Factor in the Coagulation Network.
    Cimmino G; Ciccarelli G; Golino P
    Semin Thromb Hemost; 2015 Oct; 41(7):708-17. PubMed ID: 26408920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on acute coronary syndromes: the pathologists' view.
    Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
    Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombosis, physical activity, and acute coronary syndromes.
    Kumar A; Kar S; Fay WP
    J Appl Physiol (1985); 2011 Aug; 111(2):599-605. PubMed ID: 21596926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid and smooth muscle architectural pathology in the rabbit atherosclerotic vessel wall using Q-space cardiovascular magnetic resonance.
    Taylor EN; Huang N; Lin S; Mortazavi F; Wedeen VJ; Siamwala JH; Gilbert RJ; Hamilton JA
    J Cardiovasc Magn Reson; 2022 Dec; 24(1):74. PubMed ID: 36544161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
    Chiorescu RM; Mocan M; Inceu AI; Buda AP; Blendea D; Vlaicu SI
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 signaling in vascular cells: a key role in atherosclerosis?
    Mach F; Schönbeck U; Libby P
    Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture.
    Fernández-Ortiz A; Badimon JJ; Falk E; Fuster V; Meyer B; Mailhac A; Weng D; Shah PK; Badimon L
    J Am Coll Cardiol; 1994 Jun; 23(7):1562-9. PubMed ID: 8195515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary atherosclerosis and progression to unstable plaques : Histomorphological and molecular aspects].
    Wohlschlaeger J; Bertram S; Theegarten D; Hager T; Baba HA
    Herz; 2015 Sep; 40(6):837-44. PubMed ID: 26216542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets in atherosclerosis and thrombosis.
    Schulz C; Massberg S
    Handb Exp Pharmacol; 2012; (210):111-33. PubMed ID: 22918729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease.
    Ascher S; Reinhardt C
    Eur J Immunol; 2018 Apr; 48(4):564-575. PubMed ID: 29230812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic research of fibrosis on atherosclerotic plaque stability and related drug application].
    Yin J; Li Q; Zhao Z; Yang Q; Li YJ; Chen Y; Wang YJ; Weng XG; Cai WY; Zhu XX
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):235-241. PubMed ID: 30989939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?
    Cimmino G; D'Amico C; Vaccaro V; D'Anna M; Golino P
    Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):517-23. PubMed ID: 21517734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.